Letters to the Editor
Tocilizumab and adalimumab in an 18q deletion syndrome patient with chronic arthritis
S. Kashima1, S. Tsuchida2, H. Koizumi3
- Department of Paediatrics, Akita City Hospital, Japan, Akita City, Akita, Japan.
- Department of Paediatrics, Akita University School of Medicine, Akita City, Akita, Japan.
- Department of Paediatrics, Akita City Hospital, Japan, Akita City, Akita, Japan.
CER7736
2015 Vol.33, N°1
PI 0130, PF 0131
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 25665051 [PubMed]
Received: 13/07/2014
Accepted : 01/12/2014
In Press: 09/02/2015
Published: 04/03/2015
